Kawasaki T - Search Results

1

The radical scavenger edaravone counteracts diabetes in multiple low-dose streptozotocin-treated mice.

Fukudome D, Matsuda M, Kawasaki T, Ago Y, Matsuda T. Fukudome D, et al. Among authors: kawasaki t. Eur J Pharmacol. 2008 Mar 31;583(1):164-9. doi: 10.1016/j.ejphar.2008.01.033. Epub 2008 Feb 5. Eur J Pharmacol. 2008. PMID: 18291360

2

Protective effect of the radical scavenger edaravone against methamphetamine-induced dopaminergic neurotoxicity in mouse striatum.

Kawasaki T, Ishihara K, Ago Y, Nakamura S, Itoh S, Baba A, Matsuda T. Kawasaki T, et al. Eur J Pharmacol. 2006 Aug 7;542(1-3):92-9. doi: 10.1016/j.ejphar.2006.05.012. Epub 2006 May 17. Eur J Pharmacol. 2006. PMID: 16784740

3

Role of postsynaptic serotonin1A receptors in risperidone-induced increase in acetylcholine release in rat prefrontal cortex.

Sato M, Ago Y, Koda K, Nakamura S, Kawasaki T, Baba A, Matsuda T. Sato M, et al. Among authors: kawasaki t. Eur J Pharmacol. 2007 Mar 22;559(2-3):155-60. doi: 10.1016/j.ejphar.2006.12.007. Epub 2006 Dec 29. Eur J Pharmacol. 2007. PMID: 17258195

4

Edaravone, a radical scavenger, inhibits mitochondrial permeability transition pore in rat brain.

Takayasu Y, Nakaki J, Kawasaki T, Koda K, Ago Y, Baba A, Matsuda T. Takayasu Y, et al. Among authors: kawasaki t. J Pharmacol Sci. 2007 Apr;103(4):434-7. doi: 10.1254/jphs.sc0070014. Epub 2007 Apr 4. J Pharmacol Sci. 2007. PMID: 17409627 Free article.

5

Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a radical scavenger, prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the substantia nigra but not the striatum.

Kawasaki T, Ishihara K, Ago Y, Baba A, Matsuda T. Kawasaki T, et al. J Pharmacol Exp Ther. 2007 Jul;322(1):274-81. doi: 10.1124/jpet.106.119206. Epub 2007 Apr 11. J Pharmacol Exp Ther. 2007. PMID: 17429058

6

Nitric oxide-induced apoptosis in cultured rat astrocytes: protection by edaravone, a radical scavenger.

Kawasaki T, Kitao T, Nakagawa K, Fujisaki H, Takegawa Y, Koda K, Ago Y, Baba A, Matsuda T. Kawasaki T, et al. Glia. 2007 Oct;55(13):1325-33. doi: 10.1002/glia.20541. Glia. 2007. PMID: 17626263

7

Galantamine improves apomorphine-induced deficits in prepulse inhibition via muscarinic ACh receptors in mice.

Yano K, Koda K, Ago Y, Kobayashi H, Kawasaki T, Takuma K, Matsuda T. Yano K, et al. Among authors: kawasaki t. Br J Pharmacol. 2009 Jan;156(1):173-80. doi: 10.1111/j.1476-5381.2008.00037.x. Br J Pharmacol. 2009. PMID: 19133998 Free PMC article.

8

Galantamine and donepezil differently affect isolation rearing-induced deficits of prepulse inhibition in mice.

Koda K, Ago Y, Kawasaki T, Hashimoto H, Baba A, Matsuda T. Koda K, et al. Among authors: kawasaki t. Psychopharmacology (Berl). 2008 Feb;196(2):293-301. doi: 10.1007/s00213-007-0962-1. Epub 2007 Oct 3. Psychopharmacology (Berl). 2008. PMID: 17912499

9

A neuroprotective agent, T-817MA (1-{3-[2-(1-benzothiophen-5-yl)ethoxy]propyl} azetidin-3-ol maleate), prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice.

Kawasaki T, Ago Y, Kitao T, Nashida T, Takagi A, Takuma K, Matsuda T. Kawasaki T, et al. Neuropharmacology. 2008 Oct;55(5):654-60. doi: 10.1016/j.neuropharm.2008.05.032. Epub 2008 Jun 5. Neuropharmacology. 2008. PMID: 18573265

10

SEA0400, a specific Na+/Ca2+ exchange inhibitor, prevents dopaminergic neurotoxicity in an MPTP mouse model of Parkinson's disease.

Ago Y, Kawasaki T, Nashida T, Ota Y, Cong Y, Kitamoto M, Takahashi T, Takuma K, Matsuda T. Ago Y, et al. Among authors: kawasaki t. Neuropharmacology. 2011 Dec;61(8):1441-51. doi: 10.1016/j.neuropharm.2011.08.041. Epub 2011 Sep 2. Neuropharmacology. 2011. PMID: 21903118

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,373 results

Search Page

Filters